Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260244 · ClinicalTrials.gov registry record
EnSite Precision Observational Study
A clinical trial of Cardiac Arrhythmia, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,065
- Enrollment target
- 7
- Study locations
NCT03260244: Completed study of Cardiac Arrhythmia, sponsored by Abbott Medical Devices.
NCT03260244 is a study of Cardiac Arrhythmia that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,065 participants, above the 125-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (752% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03260244, a study of Cardiac Arrhythmia, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,065 participants
- Enrollment target
- 7
- Study locations
Study Summary
This document is a clinical investigation plan (CIP) for the EnSite Precision Observational Study. This clinical study is intended to quantify and characterize the usage of the EnSite Precision™ Cardiac Mapping System (Software version 2.0.1 or higher) in a real-world environment. This study will be conducted in patients who are indicated for a cardiac electrophysiological (EP) mapping and radio frequency ablation procedure using a three-dimensional system.
Primary Outcome
The number and proportion of subjects with acute success will be summarized. Acute success was defined as the physician's goal or intention for the procedure.
Conditions Studied
Interventions
- PROCEDURE cardiac mapping and radiofrequency ablation procedure
Study Locations (7)
Arkansas
- Cardiology Associates of North East Arkansas - Jonesboro
- Arkansas Cardiology - Little Rock
Alabama
- Baptist Medical Center Princeton - Birmingham
Florida
- Bethesda Memorial Hospital - Boynton Beach
Missouri
- Barnes-Jewish Hospital - St Louis
Nebraska
- Bryan LGH Medical Center East - Lincoln
Wisconsin
- Aurora Medical Group - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,065 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2020-03-31 |
What the finished NCT03260244 record still lists
NCT03260244 is an observational study that tracks outcomes without assigning an intervention. Its 1,065 participants enrollment target places it among the larger protocols in the corpus, above the 125-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (752% higher).
The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which cardiac mapping and radiofrequency ablation procedure is the first listed.
NCT03260244 lists 7 locations in 6 states (Arkansas, Alabama, Florida).
Frequently Asked Questions
What is clinical trial NCT03260244 about?
NCT03260244 is a clinical study titled "EnSite Precision Observational Study". This document is a clinical investigation plan (CIP) for the EnSite Precision Observational Study. This clinical study is intended to quantify and characterize the usage of the EnSite Precision™ Cardiac Mapping System (Software version 2.0.1 or higher) in a real-world environment. This study will b...
What is the current status of trial NCT03260244?
This trial is currently completed. The enrollment target is 1,065 participants. The study started on 2017-09-12. Estimated completion is 2020-03-31.
What conditions does trial NCT03260244 study?
This clinical trial studies the following conditions: Cardiac Arrhythmia.
What interventions are being tested in trial NCT03260244?
The interventions under investigation include: cardiac mapping and radiofrequency ablation procedure (PROCEDURE).
Who is sponsoring clinical trial NCT03260244?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03260244 being conducted?
This trial has 7 study locations across Alabama, Arkansas, Florida, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03260244's enrollment target sits among peer trials
1,065 1st of 12 higher than 12 of 12 other Cardiac Arrhythmia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrhythmia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
ACTIVE NOT RECRUITING
-
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
ACTIVE NOT RECRUITING · NA
-
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
COMPLETED · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
COMPLETED · NA
-
SJM MRI Diagnostic Imaging Registry (IDE)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI